コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 assignment of a lesion level in a fetus with myelomeningocele.
2 ent questions that surround the newborn with myelomeningocele.
3 n which the affected child had a lumbosacral myelomeningocele.
4 ic patients with non-syndromic lumbar-sacral myelomeningocele.
5 nts who have undergone fetal repair of their myelomeningoceles.
10 ccurs in a large percentage of children with myelomeningocele and is the leading cause of death in th
11 s or older with a diagnosis of spina bifida (myelomeningocele and nonmyelomeningocele) whose primary
15 r study suggests that intrauterine repair of myelomeningocele decreases the incidence of hindbrain he
17 of prenatal vs standard postnatal repair for myelomeningocele, found that prenatal repair reduced hyd
18 defect; however, whether in utero repair of myelomeningocele improves neurologic outcome in infants
24 or congenital anomalies, including repair of myelomeningocele (MMC, n=51), resection of intrathoracic
26 ries); the defects included two instances of myelomeningocele, one of anencephaly, one of encephaloce
28 ple of 29 study patients with isolated fetal myelomeningocele referred for intrauterine repair that w
29 first 100 fetuses who underwent intrauterine myelomeningocele repair were the basis for this study.
30 functioning benefits of prenatal repair for myelomeningocele reported at age 30 months persisted int
34 Spina bifida (SB) patients afflicted with myelomeningocele typically possess a neurogenic urinary
35 nts who have undergone fetal repair of their myelomeningocele with respect to neurodevelopmental outc